John P. Throup

机构：Jnana Therapeutics (United States)

发表论文 46 篇 · 总被引 3002 次 · h-index 14

代表论文

• Construction and analysis ofluxCDABE-based plasmid sensors for investigatingN-acyl homoserine lactone-mediated quorum sensing (1998 · FEMS Microbiology Letters · 被引 593)
• Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial (2022 · Journal of the American Academy of Dermatology · 被引 372)
• A genomic analysis of two‐component signal transduction in Streptococcus pneumoniae (2000 · Molecular Microbiology · 被引 320)
• Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial (2022 · Journal of the American Academy of Dermatology · 被引 300)
• Quorum sensing: a population-density component in the determination of bacterial phenotype (1996 · Trends in Biochemical Sciences · 被引 292)
• A novel strategy for the isolation of luxl homologues: evidence for the widespread distribution of a LuxR:Luxl superfamily in enteric bacteria (1993 · Molecular Microbiology · 被引 207)